ORG 9935

Drug Profile

ORG 9935

Latest Information Update: 08 Jan 2001

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Organon
  • Class Cardiotonics; Contraceptives; Thiophenes
  • Mechanism of Action Type 3 cyclic nucleotide phosphodiesterase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Pregnancy

Most Recent Events

  • 08 Jan 2001 Discontinued-Preclinical for Pregnancy (Prevention) in Netherlands (Unknown route)
  • 27 Oct 1998 New profile
  • 27 Oct 1998 Preclinical development for Pregnancy (Prevention) in Netherlands (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top